Stock DXR DAXOR CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Daxor Corporation

Equities

DXR

US2394671034

Real-time Estimate Cboe BZX
Other stock markets
 01:59:57 2024-06-26 pm EDT 		5-day change 1st Jan Change
9.57 USD +2.24% Intraday chart for Daxor Corporation +6.00% -2.50%
Jun. 05 Daxor Corporation Appoints John L. Jefferies as Chief Medical Officer CI
Apr. 16 Daxor Corporation Announces Two New Studies Validating the Clinical Benefits of Daxor?s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Daxor Corporation Appoints John L. Jefferies as Chief Medical Officer
CI
Daxor Corporation Appoints Caleb Desrosiers, JD, MPA to its Board of Directors
CI
Daxor Corp. Approves Annual Dividend, Payable on December 29, 2016; Names Michael Feldschuh as President and Chief Executive Officer on Permanent Basis
CI
Daxor Corporation Announces Executive Changes
CI
Daxor Corp. Appoints Michael Feldschuh as President and Chief Executive Officer on a Temporary Basis; Declares Increase in Dividend for 2015, Payable on December 29, 2015
CI
Daxor Corporation Appoints Lisa Quartley as its First SVP, Marketing and Commercial Development
CI
Daxor Corp Appoints Michael Feldschuh as Executive Vice President
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DXR Stock
  4. News Daxor Corporation
  5. Insiders